CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for I
The goal of this clinical trial is to compare the effectiveness and safety of CT-guided versus fluoroscopy-guided trigeminal ganglion radiofrequency thermocoagulation (TG-RFT) in treating idiopathic trigeminal neuralgia (TN) in adults aged 18 and older. The main questions it aims to answer are: * Does CT-guided TG-RFT
| Condition(s) | Trigeminal Neuralgia, Trigeminal Neuralgia, Idiopathic |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to compare the effectiveness and safety of CT-guided versus fluoroscopy-guided trigeminal ganglion radiofrequency thermocoagulation (TG-RFT) in treating idiopathic trigeminal neuralgia (TN) in adults aged 18 and older. The main questions it aims to answer are: * Does CT-guided TG-RFT provide better pain relief compared to fluoroscopy-guided TG-RFT? * What are the differences in medication consumption between the two methods? * What are the procedure-related adverse events for both methods? Investigators will compare CT-guided TG-RFT to fluoroscopy-guided TG-RFT to see if one method is superior in treating idiopathic TN. Participants will: * Undergo either CT-guided or fluoroscopy-guided TG-RFT procedure * Be monitored post-procedure and followed up at 1, |
| Who can participate | Inclusion Criteria: * Age \>18 years * Idiopathic trigeminal neuralgia (TN) based on the International Headache Society criteria * Pain for at least six months and a NRS score greater than 6 despite medical treatment * Able to provide informed consent. * Agree to follow the study procedures and attend follow-up visits. Exclusion Criteria: * Vascular compression of the trigeminal nerve by MRI and MRI angiography and the presence of secondary causes such as multiple sclerosis * Trigeminal autonomic cephalalgias accompanied by autonomic symptoms * Dental or temporomandibular joint pathologies * Previous interventional procedures or surgery for TN * Coagulopathy or use of antiaggregants and anticoagulants * Cardiac pacemaker * Renal-hepatic insufficiency * Diagnosis of psychiatric illness * Ma |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Lead sponsor | Zagazig University |
| Locations | Zagazig, Sharqia Province, Egypt |
| Start date | 2024-11-10 |
| NCT ID | NCT06620172 |
| Official listing | https://clinicaltrials.gov/study/NCT06620172 |